FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

MOONLAKE IMMUNOTHERAPEUTICS: cashflow_financing

One fact, its scope and the complete path back to the official record.

Period: 2023-01-01 – 2023-12-31Status: supersededProvenance attached

Cite: FACTANKER, https://factanker.com/fact/818bb0da-8046-40da-9686-2fc2c7d7551b

Reported value

$479.702M{"amount": 479701508, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Entity
MOONLAKE IMMUNOTHERAPEUTICS
Metric
cashflow_financing
Period
2023-01-01 – 2023-12-31
Status
superseded
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001821586-24-000008 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T18:19:56.383138+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001821586/cashflow-financing/2023-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.